| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 08/12/2003 | US6605631 Ortho-substituted 2-methoxyiminophenyl-N-methylacetamides |
| 08/12/2003 | US6605623 Prevention of asthma and other allergic diseases |
| 08/12/2003 | US6605615 Administering to a patient suffering from hypercholesterolemia, hyperlipedimea and other metabolic disorders an effective amount of hydrozone, oxime or imine derivatives |
| 08/12/2003 | US6605608 Amino acid derivatives and drugs containing the same as the active ingredient |
| 08/07/2003 | WO2003064411A1 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes |
| 08/07/2003 | WO2003064386A1 Delta1-pyrrolines for use as pesticides |
| 08/07/2003 | WO2003064385A2 Delta1-pyrrolines and their use as pest control agents |
| 08/07/2003 | WO2003064384A2 Environment friendly reagents and process for trifluoromethylsulfinylation of organic compounds |
| 08/07/2003 | WO2003063861A1 Fibrosis inhibitor |
| 08/07/2003 | WO2003063796A2 Heterocyclic arylsulfonamidobenzylic compounds |
| 08/07/2003 | WO2003063576A2 Arylsulfonamidobenzylic compounds |
| 08/07/2003 | WO2003030886A3 Allylamides useful in the treatment of alzheimer's disease |
| 08/07/2003 | US20030149303 Simultaneous halogenation and hydroxylation under lactonization, azidation, then amination to form 2(S),4(S),5(S),7(S)-2,7-dialkyl-4-hydroxy-5-amino-8-aryl-octanoyl amides |
| 08/07/2003 | US20030149279 Dissolving crystalline atorvastatin calcium in a non-hydroxylic solvent, adding a non-polar hydrocarbon antisolvent to precipitate atovastatin calcium, removing the solvent by filtration to form amorphous atorvastatin calcium |
| 08/07/2003 | US20030149086 EP4 receptor selective agonists in the treatment of osteoporosis |
| 08/07/2003 | US20030149083 For therapy of inflammatory diseases, rheumatoid arthritis, inflammatory bowel diseases, systemic erythematodes, multiple sclerosis, Sjogren's syndrome, asthma, psoriasis, allergy, diabetes, cardiovascular diseases, arterial sclerosis |
| 08/07/2003 | US20030149081 For therapy and prophylaxis of asthma, seasonal and perennial allergic rhinitis, sinusitus, conjunctivitis, food allergy, scombroid poisoning, psoriasis, urticaria, pruritus, eczema, inflammatory bowel disease, atherosclerosis |
| 08/07/2003 | US20030149055 Bicyclic compounds as inhibitors of chemokine binding to US28 |
| 08/07/2003 | US20030149047 Novel compounds |
| 08/07/2003 | US20030147845 O2-arylated or O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and O2-substituted 1-[(2-carboxylato) pyrrolidin-1-yl]diazen-1-ium-1,2-diolates |
| 08/07/2003 | CA2474702A1 Heterocyclic arylsulfonamidobenzylic compounds |
| 08/07/2003 | CA2474594A1 Delta1-pyrrolines |
| 08/07/2003 | CA2474433A1 Arylsulfonamidobenzylic compounds |
| 08/06/2003 | EP1333025A1 Cyanopyrrolidine derivatives |
| 08/06/2003 | EP1332196A1 Blends of quinone alkide and nitroxyl compounds as polymerization inhibitors |
| 08/06/2003 | EP1332131A2 Acid derivatives useful as serine protease inhibitors |
| 08/06/2003 | EP1332130A2 Atorvastatin hemi-calcium form vii |
| 08/06/2003 | EP1332129A2 Acid derivatives useful as serine protease inhibitors |
| 08/06/2003 | EP1332127A2 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis |
| 08/06/2003 | EP1331922A1 Photo-labile pro-fragrance conjugates |
| 08/06/2003 | EP1109811B1 Pyrrolobenzodiazepines |
| 08/06/2003 | EP0983064B1 PYRROLES AS sPLA2 INHIBITORS |
| 08/06/2003 | EP0821674B1 Cyclic amidino agents useful as nitric oxide synthase inhibitors |
| 08/06/2003 | CN1434813A Pyrrolidine derivatives cyclic AMP-specific phosphodiesterase inhibitors |
| 08/06/2003 | CN1434799A Cyclic amp-specific phosphodiesterase inhibitors |
| 08/06/2003 | CN1434798A Pyrrolidines which inhibit CAMP-specific PDE |
| 08/06/2003 | CN1434797A Hydrazone and oxime derivatives of pyrrolidine as AMP-specific phosphodiesterase inhibitons |
| 08/06/2003 | CN1434712A Nitrosated and nitrosylated cyclooxygenase-2 inhibitors compositions and methods of use |
| 08/06/2003 | CN1434035A Three-position sustituted pyrrole derivative and preparation process thereof |
| 08/05/2003 | US6603046 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. |
| 08/05/2003 | US6603021 Methods of making pyrrolidones |
| 08/05/2003 | US6602987 4'-hydroxyazobenzene-2-carboxylic acid (HABA) compounds; useful as reagents for labeling, isolation and detection of biological molecules |
| 08/05/2003 | US6602907 Treatment of breast cancer |
| 08/05/2003 | US6602879 Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases |
| 08/05/2003 | US6602874 5-(2-(4-methylpiperazin-1-yl)-phenyl)- furan-2-carboxylic acid 4-chlorobenzylamide, for example; treating or preventing migraine, depression and other disorders for which a 5-HT1, agonist or antagonist is indicated |
| 08/05/2003 | CA2275827C Method for treating glaucoma |
| 07/31/2003 | WO2003062252A1 Edg receptor agonists |
| 07/31/2003 | WO2003062228A1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection |
| 07/31/2003 | WO2003062224A1 Aza-cyclic compounds as modulators of acetylcholine receptors |
| 07/31/2003 | WO2003061643A1 Pharmaceutical composition that is used to control blood glucose in patients with type 2 diabetes |
| 07/31/2003 | WO2003027061A3 Muscarinic agonists |
| 07/31/2003 | WO2003002596A3 Use of dipeptidyl peptidase iv inhibitors as therapeutics for neurological disorders |
| 07/31/2003 | WO2002094767A3 Trisubstituted-n-[(1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors |
| 07/31/2003 | US20030144551 Methods of making intermediates from polyhydroxyalkanoates |
| 07/31/2003 | US20030144543 Microwave irradiation process for preparing methyl esters |
| 07/31/2003 | US20030144526 Calcium receptor-active compounds |
| 07/31/2003 | US20030144504 Dialkyl-halogenophenyl-substituted ketoenols |
| 07/31/2003 | US20030144338 Pyrrole derivative |
| 07/31/2003 | US20030144292 Protease inhibitors such as N-((4'-Methoxy-(1,1'-biphenyl)-4-yl)-sulfonyl-N-methyl-amino)-(4 -hydroxycyclohexan-1-yl)-acetic acid for prophylaxis of neurodegenerative diseases, vision defects, skin disorders or as antiinflammatory agents |
| 07/31/2003 | US20030144273 2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity |
| 07/31/2003 | US20030144272 Heterocyclic amines such as 2-(2-(N-Methylsulfamoyl)-4-methoxy -phenyl)-N-methyl-N-((1S)-1-phenyl-2-((1-pyrrolidinyl)ethyl)) acetamide, administered as analgesics |
| 07/31/2003 | US20030144270 Neurokinin receptor antagonists comprising heterocyclic amides used as antiemetics, antidepressants and/or antitussive agents |
| 07/31/2003 | US20030144267 Novel compounds |
| 07/31/2003 | US20030144264 Carbapenems containing a carboxy substituted phenyl group and useful for treating bacterial infections in mammals and humans |
| 07/31/2003 | US20030144261 A cyclic peptide useful for treating eating disorder and diabetes |
| 07/31/2003 | US20030144253 Useful for treating or preventing neuronal damage associated with neurological diseases |
| 07/31/2003 | US20030140431 3-(2,5-Diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds |
| 07/30/2003 | EP1331222A1 Environment friendly reagents and process for halogenoalkylsulfinylation of organic compounds |
| 07/30/2003 | EP1330464A2 Phosphino-aminophosphines, catalyst complexes and enantioselective hydrogenation |
| 07/30/2003 | EP1330430A2 Integrin receptor inhibitors |
| 07/30/2003 | EP1252141B1 Tosylproline analogs as thymidylate synthase inhibitors |
| 07/30/2003 | EP0988284B1 A process for the production of n-methyl pyrrolidone |
| 07/30/2003 | CN1433402A Cycloamine CCR5 receptor antagonists |
| 07/30/2003 | CN1116281C Acryloyl substituted distamycin derivative, process for preparing them,and use as antitumor and antiviral agents |
| 07/30/2003 | CN1116271C Method of producing 2-substituted-3,4-fused heterocycle benzoic acid |
| 07/29/2003 | US6600058 Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments |
| 07/29/2003 | US6600051 Factory scale process for producing crystalline atorvastatin trihydrate hemi calcium salt |
| 07/29/2003 | US6599943 Preventive treatment, related to the radical generating nature of the xanthine dehydrogenase/xanthine oxidase |
| 07/29/2003 | US6599932 Highly selective in killing tumor cells but not normal cells |
| 07/29/2003 | US6599930 Coniosetin and derivatives thereof, process for the preparation and the use thereof |
| 07/29/2003 | US6599919 Administering reversible competitive inhibitor of enzyme in an amount effective to enhance activity of enzyme in cell |
| 07/29/2003 | US6599894 Competitive inhibitors of trypsin-like proteases, such as thrombin, and in treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants |
| 07/29/2003 | CA2059449C Process for the synthesis of citroconimides |
| 07/24/2003 | WO2003059905A1 Pyrrolidone carboxamides |
| 07/24/2003 | WO2003059881A2 Dna minor groove binding compounds |
| 07/24/2003 | WO2003059880A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 07/24/2003 | WO2003059341A1 1,3-disubstituted and 1,3,3,-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 07/24/2003 | WO2003059335A1 Phenyl sulfoxides and phenyl sulfones |
| 07/24/2003 | WO2003059265A2 Compositions and methods for treating heart failure |
| 07/24/2003 | WO2003046200A3 Methods for ligand discovery |
| 07/24/2003 | WO2003032910A3 Carbinols for the treatment of neuropathic dysfunction |
| 07/24/2003 | US20030139605 Antiproliferative agents, treating or preventing osteoporosis, inflammation, and angiogenesis disorders, treating liver cancer |
| 07/24/2003 | US20030139453 Difluorobutyric acid metalloprotease inhibitors |
| 07/24/2003 | US20030139448 Antidiarrhea agents; gastrointestinal disorders |
| 07/24/2003 | US20030139406 Antiinflammatory agents; antidepressants; respiratory system disorders; cognition activators |
| 07/24/2003 | US20030139405 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 07/24/2003 | US20030139404 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents |
| 07/24/2003 | CA2473374A1 Phenyl sulfoxides and phenyl sulfones |
| 07/24/2003 | CA2472469A1 1,3-disubstituted and 1,3,3,-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 07/24/2003 | CA2471620A1 Pyrrolidone carboxamides |